Literature DB >> 9232546

Biochemical basis for deficient paracetamol glucuronidation in cats: an interspecies comparison of enzyme constraint in liver microsomes.

M H Court1, D J Greenblatt.   

Abstract

Unlike most other mammalian species, domestic cats glucuronidate phenolic compounds poorly and are therefore highly susceptible to the toxic side effects of many drugs, including paracetamol. In this study, we evaluated the role of enzyme constraint, a characteristic that limits the activity of all uridine 5'-diphosphoglucuronosyltransferase (UGT) enzymes, in the aetiology of this species-dependent defect of drug metabolism. Detergent activation experiments were performed using hepatic microsomes from cats (4), dogs (4), man (4), and 6 other mammalian species (1 liver each). In addition, we used microsomes from Gunn rats which are sensitive to paracetamol toxicity because of a genetic defect affecting all family 1 UGTs. Increase in paracetamol-UGT activity at optimum concentrations of detergent was used as an index of enzyme constraint. Native activity (measured in the absence of detergent) was less than one-sixth in cats compared with other species. Optimum detergent treatment tended to enhance rather than abolish this difference, however, indicating relatively lower levels of constraint of paracetamol-UGT in cats compared with other species. Similarly, detergent treatment failed to reduce the native activity difference between homozygous mutant and normal Gunn rats. Initially CHAPS (3-(3-cholamidopropyl)-dimethylammonio-1-propanesulphonic acid) was used as the detergent activator; in 3 of 4 microsomal preparations from man, however, inhibition rather than activation was observed at all detergent concentrations used. Studies were repeated using the non-ionic detergent, Brij 58 (polyoxyethylene 20-cetyl ether), which resulted in similar although more profound activation and no inhibition. We conclude that deficient paracetamol glucuronidation in cats does not result from increased paracetamol-UGT constraint in this species compared with other mammalian species. Other causes, such as differences in enzyme protein concentration or substrate affinity might be responsible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232546     DOI: 10.1111/j.2042-7158.1997.tb06822.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Enhanced phase II detoxification contributes to beneficial effects of dietary restriction as revealed by multi-platform metabolomics studies.

Authors:  He Wen; Hye-Ji Yang; Yong Jin An; Joon Mee Kim; Dae Hyun Lee; Xing Jin; Sung-Woo Park; Kyung-Jin Min; Sunghyouk Park
Journal:  Mol Cell Proteomics       Date:  2012-12-09       Impact factor: 5.911

2.  Evolution of a major drug metabolizing enzyme defect in the domestic cat and other felidae: phylogenetic timing and the role of hypercarnivory.

Authors:  Binu Shrestha; J Michael Reed; Philip T Starks; Gretchen E Kaufman; Jared V Goldstone; Melody E Roelke; Stephen J O'Brien; Klaus-Peter Koepfli; Laurence G Frank; Michael H Court
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

3.  Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.

Authors:  Yuki Kutsuno; Kyohei Sumida; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2013-09-03

4.  The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model.

Authors:  Rotem Ben-Shachar; Yifei Chen; Shishi Luo; Catherine Hartman; Michael Reed; H Frederik Nijhout
Journal:  Theor Biol Med Model       Date:  2012-12-19       Impact factor: 2.432

5.  In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula).

Authors:  Aaron Michael Izes; Benjamin Kimble; Jacqueline Marie Norris; Merran Govendir
Journal:  PLoS One       Date:  2020-04-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.